Skip to main content

News Releases

Menu
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
December 13, 2018
CHMP Grants Positive Opinion for New Indication of Clovis Oncology’s Rubraca®▼ (rucaparib) Tablets as Maintenance Treatment for Women with Relapsed Ovarian Cancer Download PDF format download (opens in new window)
December 4, 2018
Clovis Oncology Announces Positive Outcome in European Opposition Proceeding Related to Rubraca® Download PDF format download (opens in new window)
November 20, 2018
Clovis Oncology Announces Second U.S. Patent Issued in Rucaparib High Dosage Strength Tablet Patent Family with Expiration in 2035 Download PDF format download (opens in new window)
November 7, 2018
Clovis Oncology to Present at the Credit Suisse 27th Annual Healthcare Conference Download PDF format download (opens in new window)
October 30, 2018
Clovis Oncology Announces Third Quarter 2018 Operating Results Download PDF format download (opens in new window)
October 19, 2018
Clovis Oncology Presents Initial Results from the Ongoing Rubraca® (rucaparib) TRITON Program in Metastatic Castration Resistant Prostate Cancer (mCRPC) at ESMO 2018 Congress Download PDF format download (opens in new window)
October 16, 2018
Clovis Oncology to Announce Third Quarter 2018 Financial Results and Host Webcast Conference Call on October 30 Download PDF format download (opens in new window)
October 11, 2018
Clovis Oncology Appoints Two New Directors to its Board Download PDF format download (opens in new window)
October 3, 2018
Clovis Oncology to Highlight Results from Rubraca® (rucaparib) TRITON Prostate Program at ESMO 2018 Congress Download PDF format download (opens in new window)
October 2, 2018
Clovis Oncology Receives Breakthrough Therapy Designation for Rubraca® (rucaparib) for Treatment of BRCA1/2-Mutated Metastatic Castration Resistant Prostate Cancer (mCRPC) Download PDF format download (opens in new window)
September 6, 2018
Clovis Oncology to Present at the Morgan Stanley Global Healthcare Conference Download PDF format download (opens in new window)
August 8, 2018
Clovis Oncology Announces First Patient Enrolled in the Phase 3 ATHENA Trial Download PDF format download (opens in new window)
August 1, 2018
Clovis Oncology Announces Second Quarter 2018 Operating Results Download PDF format download (opens in new window)
July 18, 2018
Clovis Oncology to Announce Second Quarter 2018 Financial Results and Host Webcast Conference Call on August 1 Download PDF format download (opens in new window)
July 5, 2018
Clovis Oncology Receives EMA Validation for its Application for a New Indication for Rubraca®▼ (rucaparib) as Maintenance Treatment for Women with Recurrent Ovarian Cancer Download PDF format download (opens in new window)
June 11, 2018
Clovis Oncology to Present at the Goldman Sachs 39th Annual Global Healthcare Conference 2018 Download PDF format download (opens in new window)
June 4, 2018
Clovis Oncology Submits Application to EMA to Expand Use of Rubraca®▼ (rucaparib) to Include Maintenance Treatment for Women with Recurrent Ovarian Cancer Download PDF format download (opens in new window)
June 3, 2018
Clovis Oncology and Immunomedics Announce Planned Clinical Collaboration to Study Combination Therapies in Metastatic Triple-Negative Breast and Urothelial Cancers Download PDF format download (opens in new window)
May 29, 2018
Clovis Oncology Announces European Commission Authorization of Rubraca® (rucaparib) for Women with Recurrent Ovarian Cancer Download PDF format download (opens in new window)
May 16, 2018
Clovis Oncology Announces Presentations at 2018 ASCO Annual Meeting Download PDF format download (opens in new window)
May 9, 2018
Clovis Oncology to Present at the Bank of America Merrill Lynch Healthcare Conference 2018 Download PDF format download (opens in new window)
May 9, 2018
CORRECTING and REPLACING Clovis Oncology to Present at the Bank of America Merrill Lynch Healthcare Conference 2018 Download PDF format download (opens in new window)
May 8, 2018
Clovis Oncology Announces First Quarter 2018 Operating Results Download PDF format download (opens in new window)
April 24, 2018
Clovis Oncology to Announce First Quarter 2018 Financial Results and Host Webcast Conference Call on May 8 Download PDF format download (opens in new window)
April 16, 2018
Clovis Oncology Announces Pricing of Public Offerings of Convertible Senior Notes and Common Stock Download PDF format download (opens in new window)
April 16, 2018
Clovis Oncology Announces Proposed Offerings of Convertible Senior Notes and Common Stock Download PDF format download (opens in new window)
April 6, 2018
Rubraca® (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer Download PDF format download (opens in new window)
March 23, 2018
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets Download PDF format download (opens in new window)
March 23, 2018
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe Download PDF format download (opens in new window)
March 8, 2018
Clovis Oncology Announces Notice of Allowance for Rucaparib High Dosage Strength Tablet Patent with Expiration in 2035 Download PDF format download (opens in new window)
March 7, 2018
Clovis Oncology to Present at the Barclays Global Healthcare Conference Download PDF format download (opens in new window)
February 26, 2018
Clovis Oncology Announces 2017 Operating Results Download PDF format download (opens in new window)
February 21, 2018
Clovis Oncology Receives Positive Trend Vote from CHMP in European Regulatory Review for Rucaparib Ovarian Cancer Treatment Indication Download PDF format download (opens in new window)
February 12, 2018
Clovis Oncology to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Webcast Conference Call on February 26 Download PDF format download (opens in new window)
January 4, 2018
Clovis Oncology to Present at the 36th Annual J.P. Morgan Healthcare Conference Download PDF format download (opens in new window)